Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huaier Granule in Post-Operative Ovarian, Fallopian Tube, and Peritoneal Cancer
NCT05792254Phase 2Unknown
- Sponsor
- Ruijin Hospital
- Start
- May 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of huaier granule in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Ruijin Hospital. Status: unknown.
02
Drugs
huaier granule
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT05792254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05792254.